Antihypertensive treatment and US trends in stroke mortality, 1962 to 1980

M Casper, S Wing, D Strogatz, C E Davis, H A Tyroler, M Casper, S Wing, D Strogatz, C E Davis, H A Tyroler

Abstract

Objectives: This study examines the association between increases in antihypertensive pharmacotherapy and declines in stroke mortality among 96 US groups stratified by race, sex, age, metropolitan status, and region from 1962 to 1980.

Methods: Data on the prevalence of controlled hypertension and socioeconomic profiles were obtained from three successive national health surveys. Stroke mortality rates were calculated using data from the National Center for Health Statistics and the Bureau of the Census. The association between controlled hypertension trends and stroke mortality declines was assessed with weighted regression.

Results: Prior to 1972, there was no association between trends in controlled hypertension and stroke mortality declines (beta = 0.04, P = .69). After 1972, groups with larger increases in controlled hypertension experienced slower rates of decline in stroke mortality (beta = 0.16, P = .003). Faster rates of decline were modestly but consistently related to improvements in socioeconomic indicators only for the post-1972 period.

Conclusions: These results do not support the hypothesis that increased antihypertensive pharmacotherapy has been the primary determinant of recent declines in stroke mortality. Additional studies should address the association between declining stroke mortality and trends in socioeconomic resources, dietary patterns, and cigarette smoking.

References

    1. J Chronic Dis. 1978;31(12):709-20
    1. Am J Public Health. 1979 Jul;69(7):680-9
    1. J Epidemiol Community Health. 1991 Dec;45(4):302-6
    1. Control Clin Trials. 1990 Feb;11(1):37-42
    1. Ann Med. 1989 Dec;21(6):409-13
    1. Lancet. 1987 Nov 7;2(8567):1067-70
    1. JAMA. 1989 Jan 6;261(1):56-60
    1. Stroke. 1989 Jan;20(1):14-21
    1. Br Med J (Clin Res Ed). 1986 Jul 5;293(6538):6-8
    1. Am J Epidemiol. 1988 May;127(5):893-904
    1. Am J Public Health. 1988 Aug;78(8):923-6
    1. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):99-118
    1. Am J Public Health. 1986 Jun;76(6):681-8
    1. Am J Epidemiol. 1986 Nov;124(5):724-37
    1. JAMA. 1970 Oct 12;214(2):301-10
    1. Am J Epidemiol. 1971 Mar;93(3):166-75
    1. Stroke. 1984 Jan-Feb;15(1):160-8
    1. Am J Epidemiol. 1983 Apr;117(4):507-15
    1. South Med J. 1982 Jan;75(1):33-8
    1. Stroke. 1982 Nov-Dec;13(6):818-21
    1. J Chronic Dis. 1963 Nov;16:1183-213
    1. Am J Public Health. 1976 Apr;66(4):354-8
    1. Int J Health Serv. 1980;10(4):563-79
    1. Am J Public Health. 1982 Dec;72(12):1336-44
    1. Milbank Mem Fund Q Health Soc. 1977 Summer;55(3):405-28
    1. Am J Epidemiol. 1976 Aug;104(2):107-23
    1. Am J Public Health. 1992 Feb;82(2):204-9
    1. Stroke. 1990 Sep;21(9):1274-9
    1. Lancet. 1986 Oct 11;2(8511):854-6
    1. JAMA. 1989 Jan 6;261(1):49-55
    1. Br Med J (Clin Res Ed). 1986 Jan 18;292(6514):191-2
    1. Stroke. 1986 Sep-Oct;17(5):831-5
    1. Am J Public Health. 1988 Sep;78(9):1187-9
    1. Annu Rev Public Health. 1987;8:441-67
    1. N Engl J Med. 1986 Sep 18;315(12):717-20
    1. J Chronic Dis. 1973 Sep;26(9):595-611
    1. Circulation. 1984 Nov;70(5):775-80

Source: PubMed

3
Předplatit